This issue of Endocrinology and Metabolism Clinics, guest edited by Dr. Albert Shieh of UCLA, is devoted to Bone Disorders. Articles in this outstanding issue include: Role of Osteocyte in Bone and Non-Bone Disease; Bone-Fat Interaction; Imaging Beyond DXA; Vitamin D in African-Americans; Pre-Menopausal Osteoporosis; Combined Pharmacologic Therapy in Osteoporosis; Drug-Related Adverse Events in Osteoporosis; Novel Therapies for Osteoporosis; Diabetes and Bone Disease; Bariatric Surgery and Bone Metabolism; Hyperparathyroidism and Bone Microarchitecture; FGF-23 Mediated Bone Disease; and Endothelin-Related Bone Disorder.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xvii 9. Erratum - p. xix 10. The Role of the Osteocyte in Bone and Nonbone Disease - p. 1 11. Fibroblast Growth Factor 23–Mediated Bone Disease - p. 19 12. Bone–Fat Interaction - p. 41 13. Endothelin Signaling in Bone - p. 51 14. Diabetes and Bone Disease - p. 63 15. Primary Hyperparathyroidism: Effects on Bone Health - p. 87 16. The Effects of Bariatric Surgery on Bone Metabolism - p. 105 17. Premenopausal Osteoporosis - p. 117 18. Assessing Vitamin D Status in African Americans and the Influence of Vitamin D on Skeletal Health Parameters - p. 135 19. Trabecular Bone Score: A New DXA–Derived Measurement for Fracture Risk Assessment - p. 153 20. Drug-Related Adverse Events of Osteoporosis Therapy - p. 181 21. Combined Pharmacologic Therapy in Postmenopausal Osteoporosis - p. 193 22. Novel Therapies for Postmenopausal Osteoporosis - p. 207 23. Index - p. 221
This issue of Endocrinology and Metabolism Clinics, guest edited by Dr. Albert Shieh of UCLA, is devoted to Bone Disorders. Articles in this outstanding issue include: Role of Osteocyte in Bone and Non-Bone Disease; Bone-Fat Interaction; Imaging Beyond DXA; Vitamin D in African-Americans; Pre-Menopausal Osteoporosis; Combined Pharmacologic Therapy in Osteoporosis; Drug-Related Adverse Events in Osteoporosis; Novel Therapies for Osteoporosis; Diabetes and Bone Disease; Bariatric Surgery and Bone Metabolism; Hyperparathyroidism and Bone Microarchitecture; FGF-23 Mediated Bone Disease; and Endothelin-Related Bone Disorder.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Foreword - p. xiii 8. Preface - p. xvii 9. Erratum - p. xix 10. The Role of the Osteocyte in Bone and Nonbone Disease - p. 1 11. Fibroblast Growth Factor 23–Mediated Bone Disease - p. 19 12. Bone–Fat Interaction - p. 41 13. Endothelin Signaling in Bone - p. 51 14. Diabetes and Bone Disease - p. 63 15. Primary Hyperparathyroidism: Effects on Bone Health - p. 87 16. The Effects of Bariatric Surgery on Bone Metabolism - p. 105 17. Premenopausal Osteoporosis - p. 117 18. Assessing Vitamin D Status in African Americans and the Influence of Vitamin D on Skeletal Health Parameters - p. 135 19. Trabecular Bone Score: A New DXA–Derived Measurement for Fracture Risk Assessment - p. 153 20. Drug-Related Adverse Events of Osteoporosis Therapy - p. 181 21. Combined Pharmacologic Therapy in Postmenopausal Osteoporosis - p. 193 22. Novel Therapies for Postmenopausal Osteoporosis - p. 207 23. Index - p. 221
